Similar articles for PMID: 18221229

Year	Number of Results
1885	1
1999	1
2001	1
2002	1
2003	3
2004	2
2005	4
2006	4
2007	8
2008	6
2009	16
2010	5
2011	5
2012	8
2013	8
2014	14
2015	4
2016	6
2017	16
2018	10
2019	14
2020	21
2021	19
2022	17
2023	7
2024	0

1

Therapeutic treatment of Alzheimer's disease using metal complexing agents.

Price KA, Crouch PJ, White AR. Price KA, et al. Recent Pat CNS Drug Discov. 2007 Nov;2(3):180-7. doi: 10.2174/157488907782411774. Recent Pat CNS Drug Discov. 2007. PMID: 18221229 Review.

2

Metal homeostasis in Alzheimer's disease.

White AR, Barnham KJ, Bush AI. White AR, et al. Expert Rev Neurother. 2006 May;6(5):711-22. doi: 10.1586/14737175.6.5.711. Expert Rev Neurother. 2006. PMID: 16734519 Review.

3

[Alzheimer disease: cellular and molecular aspects].

Octave JN. Octave JN. Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. Bull Mem Acad R Med Belg. 2005. PMID: 16768248 French.

4

The role of metals in modulating metalloprotease activity in the AD brain.

Filiz G, Price KA, Caragounis A, Du T, Crouch PJ, White AR. Filiz G, et al. Eur Biophys J. 2008 Mar;37(3):315-21. doi: 10.1007/s00249-007-0244-1. Epub 2008 Feb 13. Eur Biophys J. 2008. PMID: 18270696 Review.

5

Therapeutic redistribution of metal ions to treat Alzheimer's disease.

Crouch PJ, Barnham KJ. Crouch PJ, et al. Acc Chem Res. 2012 Sep 18;45(9):1604-11. doi: 10.1021/ar300074t. Epub 2012 Jun 29. Acc Chem Res. 2012. PMID: 22747493

6

Copper and Alzheimer's Disease.

Mathys ZK, White AR. Mathys ZK, et al. Adv Neurobiol. 2017;18:199-216. doi: 10.1007/978-3-319-60189-2_10. Adv Neurobiol. 2017. PMID: 28889269 Review.

7

Redox-active metals, oxidative stress, and Alzheimer's disease pathology.

Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Huang X, et al. Ann N Y Acad Sci. 2004 Mar;1012:153-63. doi: 10.1196/annals.1306.012. Ann N Y Acad Sci. 2004. PMID: 15105262 Review.

8

APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics.

Hussain I. Hussain I. CNS Neurol Disord Drug Targets. 2010 Aug;9(4):395-402. doi: 10.2174/187152710791556087. CNS Neurol Disord Drug Targets. 2010. PMID: 20522015 Review.

9

Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein.

Lin G, Zhu F, Kanaan NM, Asano R, Shirafuji N, Sasaki H, Yamaguchi T, Enomoto S, Endo Y, Ueno A, Ikawa M, Hayashi K, Yamamura O, Yen SH, Nakamoto Y, Hamano T. Lin G, et al. Int J Mol Sci. 2021 Nov 8;22(21):12063. doi: 10.3390/ijms222112063. Int J Mol Sci. 2021. PMID: 34769495 Free PMC article.

10

Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.

Wang P, Wang ZY. Wang P, et al. Ageing Res Rev. 2017 May;35:265-290. doi: 10.1016/j.arr.2016.10.003. Epub 2016 Nov 6. Ageing Res Rev. 2017. PMID: 27829171 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

182 results

Results by year